Information Provided By: 
Fly News Breaks for February 27, 2020
MTEM
Feb 27, 2020 | 07:12 EDT
Barclays analyst Carter Gould initiated coverage of Molecular Templates with an Overweight rating and $22 price target. The analyst initiated coverage of the U.S. Biopharmaceuticals industry with a Positive view citing waning near-term concerns on drug pricing reform, evidence of innovation and attractive valuations. He views Molecular as a differentiated early stage play.
News For MTEM From the Last 2 Days
